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Summary.-Phototherapy in the presence of haematoporphyrin derivative has been
shown to have a preferential effect on malignant tumours when compared to normal
tissue. This communication presents a comparison of the sensitivity to photo-
chemotherapy in vitro of different cell lines.
Asynchronous populations ofcells were exposed to light in the presence ofhaemato-
porphyrin derivative, and found to be inactivated with a comparable efficiency. The
lines were of human, Chinese-hamster or mouse origin and had different abilities to
form tumours after heterotransplantation into nude mice or transplantation into
syngeneic, immunosuppressed mice. Synchronized cells from 4 of the lines showed a
similar variation in sensitivity to light throughout the cell cycle. Cells near the
middle of interphase showed the highest sensitivity, whilst cells in early G1 were
found to be least sensitive towards treatment with haematoporphyrin derivative
and light.
THE INTRODUCTION of haematopor-
phyrin derivative (HPD) as a selective
tumour-seeking and photodynamically ac-
tive agent has led to the development of
a new treatment modality for cancer
(Dougherty et al., 1976a, 1978; Kelly &
Snell, 1976; Forbes et al., 1980). A selective
effect of the treatment on malignant
tissue has been demonstrated (Kelly
et al., 1975). The most probable reason
for this selectivity is a selective accumula-
tion of HPD in malignant tissue. The
results concerning uptake of HPD in
cells cultivated in vitro are, however,
contradictory. Mossman et al. (1974)
studied primary cultures from mouse or
human tissue and showed that malignant
cells had a stronger fluorescence from
bound HPD than normal cells. Dougherty
and co-workers (Chang & Dougherty,
1978; Dougherty et al., 1,981) measured
HPD uptake in cells of several species,
using absorption spectrometry. Their con-
clusion was that malignant and normal
cells bound about equal amounts of HPD.
It has also been shown that for cells in
vitro the sensitivity to treatment with
light is strongly dependent on the amount
ofporphyrin bound to the cells (Dougherty
et al., 1976b; Moan & Christensen, 1981).
Against this background we initiated the
present study to test whether established
cell lines of different origin, as well as
untransformed and transformed mouse
cells in culture, have different sensitivities
to light in the presence of HPD under
similar conditions.
NHIK 3025 cells have a pronounced
variation in sensitivity to haematopor-
phyrin (HP) combined with light through
the cell cycle, which is accompanied by a
change in the shoulder of the dose-
response curve (Christensen & Moan,
1979; Christensen et al., 1979). Cells in
early G1 are relatively resistant, but in
late G1 and S the cells become more sensi-
tive. The highest sensitivity is found in
mid S. CHO cells have been reported toT. CHRISTENSEN, K. FEREN, J. MOAN AND E. PETTERSEN
lack this variation in sensitivity during
the cell cycle, when treated with HPD
and light (Gomer, 1979, 1980; Gomer &
Smith, 1980).
Both commercially available HP and
HPD are chemically impure and consist
of several porphyrins with varying hydro-
phobicity (Bonnett et al., 1978; Clezy
et al., 1980; Moan et al., 1981; Kessel,
1981). The most hydrophobic component
of HPD is rapidly taken up by cells, and
is also the most efficient component in
introducing photodynamic damage to
cells in standard culture experiments
(Kessel, 1981; Moan et al., submitted).
This very active component is found in
only minor amounts in HP. Thus it is
expected that most of the photodynamic
damage to cells by HPD is caused by a
more hydrophobic component than is in
HP. Mechanisms of cell inactivation may
therefore be different for HPD and HP
(Sandberg & Romslo, 1981) and a re-
evaluation of the sensitivity of synchron-
ized cells is necessary.
MATERIALS AND METHODS
Cell lines.-NHIK 3025 cells were derived
from a carcinoma in situ of the cervix as
described previously (Nordbye & Oftebro,
1969; Oftebro & Nordbye, 1969). HeLa S3
cells (human cervix) were obtained from Dr
R. Munro, Christie Hospital, Manchester, in
1958. V79 cells (Chinese hamster lung fibro-
blasts) were obtained from Dr L. Revesz,
Karolinska Institute, Stockholm, in 1976.
NHIK 1922 cells were established as
described previously (Rofstad et al., 1980).
Briefly, in 1973 HeLa S3 cells were injected
s.c. into nude mice and grown as a tumour for
4 weeks. The tumour was excised and minced,
and the cells were grown as a monolayer in
vitro. At the time of the present study, the
genome of NHIK 1922 cells is composed of
normal and metacentric mouse chromosomes,
probably due to in vivo cell fusion (A.
Brogger, personal communication).
HeLa 83 and NHIK 1922 cells formed
large tumours in nude mice within 2 weeks
after inoculation of 3 x 106 cells, whereas
neither NHIK 3025 nor V79 formed a
tumour within 2 months when 3 x 106 cells
were injected (E. K. Rofstad, personal com-
munication).
Cells from the mouse embryo line C3H/
10TI Clone 8 (Cl 8) (Reznikoff et al., 1973a,b)
as well as its DMBA-transformed counter-
parts were a kind gift from Dr Harald
Saxholm, University of Oslo. It has been
reported that the different transformants
used in this study have different capacities
for forming tumours in immunosuppressed
syngeneic mice (see Saxholm, 1979). The
parent line C3H/10T1 Cl 8 does not form
tumours, whilst the most malignant clone
from this line (Type III) will form tumours
in every mouse when > 104 cells are injected.
The other types (I and II) are intermediate
with respect to transformed characteristics.
Type I shows a certain degree oftransformed
morphology, but is unable to form tumours.
Type II cells have a transformed morphology,
and form tumours at high passage numbers
(>-25).
Cell cultivation and synchronization.-
NHIK 3025, NHIK 1922 and HeLa S3 were
routinely cultivated in Medium E2a (Puck et
al., 1957) containing 30% serum. V79 cells
were cultivated in Minimal Essential Medium
with Earle's salts (Gibco, Scotland) and 10%/o
serum. All cell lines were subcultured 3 times
a week. The synchronization method has been
described previously (Pettersen et al., 1977).
Briefly, mitotic cells were selected from a
monolayer of asynchronously growing cells
by shaking the culture flasks on a reciprocal
shaker. A slight modification ofthe technique
was used for V79 cells, which were shaken for
10 sec only on the reciprocal shaker, whereas
the 3 other lines were shaken for 60 sec.
Shortly after synchronization, mitotic cells
divided and the daughter cells attached in
pairs. No attempts were made to separate the
daughter cells before treatment.
To monitor the multiplication of syn-
chronized cells, a field was delineated on the
bottom of the culture. flask The number of
cells within the field was counted by repeated
observations in an inverted microscope
(Ernst Leitz Wetzlar GmbH, W. Germany)
and growth curves were constructed.
The cells of Line C3H/10T1 Cl 8 and the
transformed counterparts were stored in
liquid N2 and subcultured twice in Eagle's
Basal Medium with 10% foetal calf serum
(Gibco) before being used in the experiments.
Labelling with HPD and irradiation.-
Haematoporphyrin HCI (Koch-Light Labora-
718PHOTODYNAMIC INACTIVATION BY HAEMATOPORPHYRIN DERIVATIVE
tories Ltd, England) was treated according
to the method of Lipson et al. (1961) as
described in Dougherty et al. (1978). The
resulting material was dissolved in 01N
NaOH and stirred 1 h at room temperature,
neutralized with 0-1N HCI and stored
frozen in the dark as a stock solution of 2-5
mg HPD/ml. Two solutions containing HPD
were used: (a) 0-25 mg/ml HPD in E2a
medium with 30% serum or (b) 0-025 mg/ml
HPD in PBS with 1% serum. Either of the
solutions was added to cells attached to
Falcon culture flasks and the flasks were
incubated at 37°C for 30 min before illumina-
tion. Light was delivered to the flasks
through the bottom while the medium was
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FiG. 1.-Dose-response curves for inactiva-
tion of asynchronously growing cells from
4 cell lines (NHIK 3025, HeLa S3, NHIK
1922 and V79) in the presence of0-25 mg/ml
HPD in 30% serum and light. Results from
one representative experiment for each cell
line are presented. The experimental points
represent the mean of 3 replicate flasks.
Bars show + s.e., when greater than
symbols.
kept at 35 + 1°C. The light source consisted
of 2 backlight lamps (330 to 380 nm; Osram
GmbH, WV. Germany) giving a light intensity
of 11 W/m2 to the cells during exposure. The
light intensity was measured with a calibrated
thermopile (Yellow Springs Instrument Co.,
Yellow Springs, Ohio). After illumination,
fresh medium was added and the cells were
further incubated at 37°C. All manipulations
of HPD-labelled cells were performed in
darkness or very dim light.
Cell survival.-Colony-forming ability was
measured for the treated cells from Lines
NHIK 3025, HeLa S3, V79 and NHIK 1922.
Exponentially growing or synchronized cells
were inoculated in numbers sufficient to give
50-300 colonies per flask in 25cm2 plastic
flasks (Falcon). Asynchronous cells were
treated 2-3h after inoculation, whilst syn-
chronized cells were treated at the desired
stage of the cell cycle. Cells giving rise to
colonies of at least 40 cells were scored as
surviving. At each dose 3 replicate flasks
were treated in every experiment. Details of
the procedure have been described previously
(Christensen & Moan, 1979, 1980; Christensen
et al., 1979).
C3H/10T1 Cl 8 cells and Transformed-Cell
Types I, II and III do not form distinct
colonies, and another method was used to
measure cell survival. The cells were inocu-
lated in 25cm2 plastic culture flasks (Falcon)
and treated with HPD and light after 20h.
Cell number was determined 241 later with a
laboratory-built volume spectrometer with
Coulter flow configuration (Steen & Lindmo,
1978).
RESULTS
Asynchronous cells
Dose-response curves from representa-
tive single experiments with cells from 4
of the cell lines treated with HPD and
light in the presence of 30% serum are
shown in Fig. 1. The light dose required
to reduce survival from 100% to 37%
(D37) can be used as a measure of the
sensitivity of the lines. Values of D37 for
independent experiments performed on
different days are shown in the Table,
which indicates no great differences in
sensitivity between the lines.
Cells from Line C3H/10T1 C18 and
Transformed-Cell Types I, II and III
were treated under low serum conditions
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TABLE.-Value8 of the light dose (D37)
required to reduce the survivalfrom 100%
to 37 % from independent experiments
with the 4 cell lines
Cell line
NHIK 3025
HeLa S3
NHIK 1922
V79
Experiment No.
1 2 3
2-2 2-7 2-3
3-0 1.9
1-7 2-5 2-2
2-3 1-6 2-0
Mean
(min)
2-4 + 0-2
2-5+05
2-1+0-2
2-0+0-2
(1%) and had similar sensitivity to HPD
and light. For clarity, Fig. 2 shows only
the inactivation of C3H/10T1 C18 cells
and Type III cells. In several separate
experiments (data not shown) NHIK
3025 cells were found to have a sensitivity
within 30% of the values shown in Fig. 2.
Synchronous cells
Fig. 3 shows the surviving fraction of
doublets of cells from Lines NHIK 3025,
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FIG. 2.- Dose-response curves for inactiva-
tion of cells from the lines C3H/1OTj C18
(solid symbols) and Type III (open sym-
bols). The cells were labelled with 0-025 mg/
ml HPD in PBS containing 10% human
serum. Each point is the mean of 2 inde-
pendent experiments with 2 replicate flasks
in each. These data are also representative
of the sensitivity of cells from Type I
Passage 19 and Type II Passages 19 and 50.
The points have been omitted for clarity.
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FIG. 3. Survival of synchronized cells from
4 cell lines after treatment with 0-25 mg/ml
HPD in 30% serum and 3 min of light.
Means of 3 replicate flasks. Bars +s.e. In
the lower part ofeach panel the relative cell
numbers as a function of time after mitotic
selection are shown for the same popula-
tions.
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HeLa 83, NHIK 1922 and V79 treated
with 0-25 mg/ml HPD in 30% serum and
light in different parts of the cell cycle.
Each value is the mean of 3 replicate
flasks. The growth curve in the lower part
of each panel shows the multiplication of
cells from the same synchronized popula-
tion as the treated cells. The bar indicating
duration of the phases has been construc-
ted on the basis of the following sources:
NHIK 3025, Pettersen et al. (1977);
HeLa S3, Ohara & Terasima (1969);
NHIK 1922, Rofstad et al. (1980); and
V79, a separate experiment.
The shape of the age-response curves
were similar for all cell lines. It is charac-
teristic that cells in the early parts of the
cell cycle are relatively resistant and that
a more sensitive stage is reached near the
middle of interphase. For all cell lines the
highest- sensitivity is found in S. Cells in
the earliest stage tested were least sensi-
tive. At this point synchronous cells of
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FIG. 4.-Survival of synchronized cells of the
line NHIK 3025 after treatment with 0-25
mg/ml HPD in 30% serum and 2 (0),
4 (0) or 6 (-) min of light. Mean of 3
replicate flasks. Bars + s.e. In the lower
part of the figure, the relative cell number
as a function of time after mitotic selection
is shown for the same population.
Lines NHIK 3025, HeLa S3 and NHIK
1922 are in G1. The relatively short G1
phase of V79 cells makes it difficult to
conclude whether the least sensitive cells
are in G1 or in early S. As the cells proceed
through the cell cycle, desynchronization
will occur. The cell populations tested in
the stage designated G2 +M will therefore
consist of cells distributed in these two
stages as well as in early G1, when the
cells will be in microcolonies with multi-
plicity 3 or 4. The present method there-
fore allows no conclusion to be drawn
about the sensitivity of cells in G2 and M.
To test whether this type of cell-cycle
49
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FiG. 5.-Survival of synchronized cells of the
line NHIK 3025 after treatment with 0 025
mg/ml HPD in 1% serum and 40 (0) or
60 (0) sec of light. Mean of 3 replicate
flasks. Bars + s.e. In the lower part of the
figure, the relative cell number as a function
of time after mitotic selection is shown for
the same population.
variation in sensitivity is general, not only
in different cell lines, but also under
different conditions, NHIK 3025 cells were
included in a series of other synchroniza-
tion experiments. In these experiments a
similar variation was found for NHIK
3025 cells treated in 30% serum as above
with 3 different light doses (Fig. 4), as
well as in a medium containing 1% human
serum in phosphate-buffered saline (Fig.
5).
DISCUSSION
The formation of tumours in nude mice
or syngeneic, immunosuppressed mice has
been used to characterize cultured cells
I_
-
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as malignant or normal (Giovanella et al.,
1974). This criterion is debatable and does
not represent the only test for malignancy.
In this study, however, this common test
makes a comparison possible both between
established cell lines of widely different
origin and between normal C3H/1OT2
cells and their transformed counterparts,
since the malignancy of all the lines in
terms of tumour-forming ability is estab-
lished. The general conclusion of the data
in this study is that the sensitivity to HPD
and light of cells treated in vitro is not
correlated with their ability to form tu-
mours in mice. The selective retention of
HPD, resulting in tumour sensitization to
light, is probably not caused by differences
in HPD binding by normal and malignant
cells. This has been indicated in experi-
ments involving cells of different types.
The C3H cells used in this study have a
relatively similar uptake of HPD (Moan et
al., submitted) irrespective their malig-
nancy. Thesametrendhasbeenreportedfor
established cell lines and primary cultures
of malignant and normal cells in vitro
(Chang & Dougherty, 1978; Dougherty
et al., 1981). That the total amount of
HPD taken up in different cells is similar
will, however, not necessarily imply that
the cells have the same light sensitivity.
The components ofHPD couldforinstance
be unequally distributed inside the cells,
more or less close to sensitive sites, and
thus give rise to different degrees ofphoto-
sensitivity. This is not the case for the
various cells treated with HPD and light
in vitro in this study. It is therefore
probable that the selective effect of HPD
photoradiation therapy on malignant
tumours in vivo is not caused by intrinsic
differences in sensitivity between normal
and malignant cells.
The organization of tumour tissue is
probably more important for the selective
effect of this mode of cancer therapy.
Musser et al. (1979) suggested that a fibrin
matrix in tumours that is not present in
normal tissue may play a role in tumour
localization by porphyrins. They found
that HPD and the two synthetic por-
phyrins meso-tetra (4-carboxyphenyl)por-
phine and meso-tetra(4-sulfonatophenyl)-
porphine bound to fibrinogen in the ab-
sence of light, and that the binding was
stimulated by light. The vascularization
of tumours may also play a role, since it
has been shown that HPD binds par-
ticularly well to the vascular stroma in
tumours (Dougherty et al., 1981).
Moan et al. (1980a) demonstrated that
the photodynamic effect of HP on NHIK
3025 cells is stronger at low pH, owing to
higher cellular uptake. This may also be a
factor that increases the sensitivity of
cancer tissue, because it is generally
believed to have a lower pH than normal
tissue.
An interesting similarity between the
4 different cell lines NHIK 3025, HeLa
S3, NHIK 1922 and V79 in this study
is the equal pattern of variation in sensi-
tivity through the cell cycle. The variation
is qualitatively similar whether the NHIK
3025 cells are treated under high- or low-
serum conditions. A medium with low
serum content allows the cells to take up
more HPD than in environments in vitro
and in vivo with a high amount of serum.
This is due to the binding capacity of
serum for porphyrins (Moan et al., 1979).
Similar variation in sensitivity throughout
the cell cycle has previously been found
for photodynamic inactivation of V79
cells in the presence of the carcinogen
7,12-Dimethylbenz(a)anthracene (DMBA)
(Utsumi & Elkind, 1979) as well as for
photodynamic inactivation ofNHIK 3025
cells in the presence of HP (Christensen
et al., 1979). On the other hand Gomer
& Smith (1980) labelled Chinese hamster
ovary (CHO) cells with HPD and illu-
minated the cells with red light, and were
unable to demonstrate any significant
variations in sensitivity during the cell
cycle. This finding is obviously in contrast
to the data presented in this communica-
tion. It is not clear, however, whether this
discrepancy is due to biological differences
between CHO cells and the different cell
lines used in this study or to differences in
the methods. The synchronization method
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used by Gomer and Smith was slightly
different from the one used in this study,
and involved cooling selected mitoses
after mitotic selection. This has been
shown to induce unbalanced growth and
cell inactivation (Pettersen et at., 1977).
Anotherpointis thattheirsynchronization
method did not allow determination of
the sensitivity of early- and mid-Gl cells.
In our work cells in these stages are
found to have the lowest sensitivity to
treatment with porphyrins and light (see
Figs 3, 4 and 5; Christensen et al., 1979;
Christensen & Moan, 1979). It is not
known which constituent of the cells is
most severely damaged by photoactivated
porphyrins. The nature of the damage
has been shown to be dependent on the
type of porphyrin involved (Sandberg &
Romslo, 1981). Since HPD containsseveral
components, one may expect damage to
cells to be introduced in several structures.
Thus it is difficult to identify the biological
changes responsible for the cyclic varia-
tions in the phototoxicity of the por-
phyrins. The most probable targets for
cell inactivation are the membrane struc-
tures of the cell (Kessel, 1977; Kohn &
Kessel, 1979; Moan et al., 1979). Variations
in membrane fluidity may play a role in
the variation in sensitivity during the
cell cycle (Christensen & Moan, 1979). The
amount of SH groups also shows cyclic
variation (Ohara & Terasima, 1969) and
the SH groups may be modified by por-
phyrins and light (Schothorst etal., 1980).
Further research is, however, necessary
before the mechanisms can be identified.
Work aimed at purifying the porphyrin
mixtures and isolating the active compo-
nent(s) will be of special importance for
this, as well as for improving the photo-
chemotherapy of cancer.
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